| P50 | author | Michael A. Pfaller | Q62070176 |
| P2093 | author name string | D J Diekema | |
| | L Boyken | |
| | R J Hollis | |
| | S A Messer | |
| | S Tendolkar | |
| P2860 | cites work | Phase 2, randomized, dose-ranging study evaluating the safety and efficacy of anidulafungin in invasive candidiasis and candidemia | Q24563657 |
| | Antifungal susceptibility survey of 2,000 bloodstream Candida isolates in the United States. | Q30452376 |
| | Susceptibility of fluconazole-resistant clinical isolates of Candida spp. to echinocandin LY303366, itraconazole and amphotericin B. | Q31440064 |
| | Susceptibilities of Candida species isolated from the lower gastrointestinal tracts of high-risk patients to the new semisynthetic echinocandin LY303366 and other antifungal agents | Q33697398 |
| | Quality control limits for broth microdilution susceptibility tests of ten antifungal agents | Q33969748 |
| | Antifungal activity of LY303366, a novel echinocandin B, in experimental disseminated candidiasis in rabbits | Q33977578 |
| | Postantifungal effects of echinocandin, azole, and polyene antifungal agents against Candida albicans and Cryptococcus neoformans | Q33979304 |
| | Pharmacokinetic and pharmacodynamic modeling of anidulafungin (LY303366): reappraisal of its efficacy in neutropenic animal models of opportunistic mycoses using optimal plasma sampling | Q33983159 |
| | Influences of methodological variables on susceptibility testing of caspofungin against Candida species and Aspergillus fumigatus | Q35102477 |
| | In vitro susceptibilities of clinical yeast isolates to a new echinocandin derivative, LY303366, and other antifungal agents. | Q35134781 |
| | In vitro activity of a new echinocandin, LY303366, compared with those of amphotericin B and fluconazole against clinical yeast isolates | Q35136251 |
| | Further standardization of broth microdilution methodology for in vitro susceptibility testing of caspofungin against Candida species by use of an international collection of more than 3,000 clinical isolates. | Q35718542 |
| | Anidulafungin: an echinocandin antifungal | Q35871936 |
| | Interlaboratory comparison of results of susceptibility testing with caspofungin against Candida and Aspergillus species | Q37157546 |
| | Caspofungin activity against clinical isolates of fluconazole-resistant Candida | Q40404311 |
| | Antifungal activity of the echinocandin anidulafungin (VER002, LY-303366) against yeast pathogens: a comparative study with M27-A microdilution method | Q44257296 |
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | fluconazole | Q411478 |
| P304 | page(s) | 5425-5427 | |
| P577 | publication date | 2005-11-01 | |
| P1433 | published in | Journal of Clinical Microbiology | Q4041880 |
| P1476 | title | In vitro activities of anidulafungin against more than 2,500 clinical isolates of Candida spp., including 315 isolates resistant to fluconazole | |
| P478 | volume | 43 | |